Recent News

• 06.11.2025 - 4th Annual Goldman Sachs Global Healthcare Conference
• 06.11.2025 - 4th Annual Goldman Sachs Global Healthcare Conference
• 06.05.2025 - Jefferies Global Healthcare Conference
• 06.05.2025 - Jefferies Global Healthcare Conference
• 06.03.2025 - Rosnilimab Updated Phase 2b Rheumatoid Arthritis (RA) Data
• 06.03.2025 - Rosnilimab Updated Phase 2b Rheumatoid Arthritis (RA) Data
• 06.03.2025 - Anaptys Announces Positive Rosnilimab Data Updated Through Six Months in Robust Phase 2b Trial in RA
• 06.03.2025 - Anaptys Announces Positive Rosnilimab Data Updated Through Six Months in Robust Phase 2b Trial in RA
• 06.03.2025 - Anaptys Announces Positive Rosnilimab Data Updated Through Six Months in Robust Phase 2b Trial in RA
• 05.27.2025 - Anaptys to Announce Updated Data from Phase 2b Trial of Rosnilimab, a PD-1 Depleter and Agonist, for Rheumatoid Arthritis on June 3, 2025

Recent Filings

• 06.03.2025 - EX-99.1 EX-99.1
• 06.03.2025 - 8-K Current report
• 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.12.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors